High Tumoral KPNA2 Expression Is a PotentialBiomarker for Poor Prognosis in Advanced Neuroblastoma Patients. [PDF]
Otake S+7 more
europepmc +1 more source
Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma. [PDF]
Koelker-Wolfe E+10 more
europepmc +1 more source
Presentation of disseminated neuroblastoma mimicking Bell's palsy: a case report. [PDF]
Gunawardana S+2 more
europepmc +1 more source
A multiparameter diagnostic model based on 2-[<sup>18</sup>F]FDG PET/CT metabolic parameters and clinical variables can differentiate high-risk and non-high-risk pediatric neuroblastoma under the revised Children's Oncology Group classification system. [PDF]
Xu Y+6 more
europepmc +1 more source
Global, regional and national burden of neuroblastoma and other peripheral nervous system tumors, 1990 to 2021 and predictions to 2035: visualizing epidemiological characteristics based on GBD 2021. [PDF]
Yue C, Zhang Q, Sun F, Pan Q.
europepmc +1 more source
Chronic diarrhea related to neuroblastoma: the important role of vasoactive intestinal peptide in tumor pathology and survival. [PDF]
Cao MY, Zhang K, Guo J, Dong F, Xu LF.
europepmc +1 more source
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial. [PDF]
Mora J+12 more
europepmc +1 more source
Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy. [PDF]
Cheng J+9 more
europepmc +1 more source
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic States. [PDF]
George SL+53 more
europepmc +1 more source